No abstract available
Keywords:
BTK inhibitors; Follicular lymphoma; Inhibiteurs de BTK; Lymphome folliculaire; Lymphoproliferative disease; Syndromes lymphoprolifératifs; Zanubrutinib.
MeSH terms
-
Antineoplastic Agents* / adverse effects
-
Antineoplastic Agents* / therapeutic use
-
Drug Resistance, Neoplasm
-
Humans
-
Lymphoma, Follicular* / drug therapy
-
Neoplasm Recurrence, Local / drug therapy
-
Piperidines* / therapeutic use
-
Protein Kinase Inhibitors / adverse effects
-
Protein Kinase Inhibitors / therapeutic use
-
Pyrazoles* / adverse effects
-
Pyrazoles* / therapeutic use
-
Pyrimidines* / therapeutic use
Substances
-
Pyrimidines
-
zanubrutinib
-
Pyrazoles
-
Antineoplastic Agents
-
Piperidines
-
Protein Kinase Inhibitors